Molecular Profi Ling Of The Residual Disease Of Triple ...
Jennifer M. Giltnane 2,5 , Kai Jennifer A. Pietenpol 4,5 , Jeffrey S. Ross 8, Gary A patients with triple-negative breast cancer (TNBC), a subtype lacking expression of estrogen receptor (ER), ... Return Doc
Mechanisms Of Cisplatin Resistance In Triple Negative Breast ...
Mechanisms of Cisplatin Resistance in Triple Negative Breast Cancer By Christopher Stephen Pendleton Thesis Submitted to the Faculty of the Graduate School of Vanderbilt University Jennifer A. Pietenpol, Ph.D. Bruce E. Carter, Ph.D. ... Read Here
PDF - Breast Cancer Research
Triple negative breast cancer Bojana Jovanovi Brian D Lehmann2, Andries Zijlstra4, Jennifer A Pietenpol1,2 and Harold L Moses1,4* Abstract Introduction: transforming growth factor beta receptor expression increases motility ... View Full Source
New Strategies For Triple-Negative Breast Cancer Deciphering ...
New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity Ingrid A. Mayer1,3, Vandana G. Abramson1,3, Brian D. Lehmann2,3, and Jennifer A. Pietenpol2,3 Abstract Triple-negative breast cancer (TNBC) is a heterogeneous disease; ... Read More
Cracking Cancer's Secret Code: Oncologist Searches For Breast ...
Triple-negative breast cancer has been defined by what it is not, but Dr. Jennifer Pietenpol and her team has identified six different subtypes of the disease ... View Video
Science Buzz! - Non-Profit Breast Cancer Organization
Science Buzz! Researchers Triple Negative Breast Cancer (TNBC) is difficult to treat because of what it lacks. The term "triple-negative breast cancer (TNBC) is just a definition of what [the cancer] isn't." explains Komen Scholar Dr. Jennifer Pietenpol, Director of the Vanderbilt ... Content Retrieval
TNBC SABC Poster 03Dec14 FINAL - Insightgenetics.com
To identify triple-negative breast cancer (TNBC) subtypes. Brian Z Ringl, David R. Houtl, Pietenpol group molecularly binned the malignancy into six distinct subtypes: TNBC_SABC Poster_03Dec14_FINAL ... Read Content
Cancer Treatment And Research - YouTube
Cancer Treatment and Research Vanderbilt Health; 105 videos; 1,943 views; Last updated on Jul 10, Preventing Breast Cancer Recurrence Through Healthy Lifestyle by Vanderbilt Health. Triple Negative Breast Cancer Research by Vanderbilt Health. 2:41. Play next; ... View Video
Susan G. Komen Research Grants Fiscal Year 2014
Susan G. Komen Research Grants – Fiscal Year 2014 Investigator(s): Jennifer Pietenpol, Ph.D. Lead Organization: Vanderbilt University These difficult-to-treat cancers are classified molecularly as triple-negative breast cancers (TNBC). ... Doc Viewer
Susan G. Komen . Research Grants – Fiscal Year 2015 . Investigator(s): Jennifer Pietenpol, Ph.D. Lead Organization: Vanderbilt University These difficult-to-treat cancers are classified molecularly as triple - negative breast cancers (TNBC). ... Doc Retrieval
DISCOVERY AND CHARACTERIZATION OF THE MTOR-P73 SIGNALING AXIS ...
DISCOVERY AND CHARACTERIZATION OF THE MTOR-P73 SIGNALING AXIS IN HUMAN CANCER By Jennifer Pietenpol. Of the 16 tumors, 8 were from triple negative breast cancer patients. The gene ... Retrieve Content
TOPIC/QUESTION TIME - Triple Negative Breast Cancer Foundation
Are the non-basal types of triple negative breast cancer? Jennifer Pietenpol 4:00 – 4:35 Where do the various subtypes overlap and what are the unifying biologic pathways with actionability? Jim Ford 4:35 – 5:10 Discussion: Lisa Carey ... Document Viewer
Supplementary Figure Legends For: Molecular Profiling Of The ...
Molecular profiling of the residual disease in triple-negative breast cancers Jennifer A. Pietenpol4,9, Jeffrey S. Ross8 Departments of Medicine1, Pathology, Microbiology & Immunology2, Cancer Biology3 and Biochemistry9; Breast Cancer Research Program4, Vanderbilt-Ingram Cancer ... View This Document
DifferentialResponsetoNeoadjuvantChemotherapyAmong 7 Triple ...
7 Triple-Negative Breast Cancer Molecular Subtypes Hiroko Masuda1,2, Keith A. Baggerly3, Ana Maria Gonzalez-Angulo2, Funda Meric-Bernstam5, Vicente Valero1,2, Brian D. Lehmann6, Jennifer A. Pietenpol6, Gabriel N. Hortobagyi2, W. Fraser Symmans3, Pietenpol, G.N. Hortobagyi, W.F. Symmans ... Read Here
PIK3CA Mutations In Androgen Receptor-positive triple ...
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to Pietenpol JA: Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. ... Fetch Full Source
Harnessing The Power Of Chemistry To Improve Human Health The ...
Triple negative breast cancer (TNBC) lacks the estrogen, progesterone, and Her2 receptors against which many of the most effective therapies are targeted. The diversity of the disease further Jennifer Pietenpol Eric Skaar Walter Chazin David Cortez ... Retrieve Here
TnBctype: A Subtyping Tool For Triple-negative Breast cancer
A subtyping Tool for Triple-negative Breast cancer Xi Chen1,2,5, Jiang Li2,5, William H. Gray2,5, Brian D. Lehmann3,5, Joshua A. Bauer4,5, Yu Shyr1,2,5 and Jennifer A. pietenpol3,5 University, Nashville, TN 37232. Corresponding author email: steven.chen@vanderbilt.edu; j.pietenpol@ ... Read Content
2015 PM Targeted Therapies Research Fast Facts
Triple negative breast cancer by Komen Scholar Dr. Jennifer Identifying new targeted therapies that can treat aggressive and drug resistant breast cancers, including HER2 and triple negative breast cancer There are at least six different types of triple negative breast cancer, which ... Return Doc
Identification Of Human triple-negative breast cancer ...
Identification of human triple-negative Xi Chen,2 Melinda E. Sanders,3 A. Bapsi Chakravarthy,4 Yu Shyr,2 and Jennifer A. Pietenpol1 1Department of Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Triple-negative breast cancer (TNBC) is a highly diverse ... Access Full Source
Clinical Implications Of Molecular Heterogeneity In triple ...
Clinical implications of molecular heterogeneity in triple negative breast cancer Brian D. Lehmann*, Jennifer A. Pietenpol Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Preston Research Building, 2200 Pierce Avenue, ... Read Here
PRINCIPAL INVESTIGATOR: Jennifer A. Pietenpol, Ph.D.
AWARD NUMBER: W81XWH-13-1-0287 TITLE: Integration of Genomic, Biologic, and Chemical Approaches to Target p53 Loss and Gain-of-Function in Triple Negative Breast Cancer ... Get Content Here
ASCO: Triple-Negative Breast Cancer Response To Neoadjuvant ...
Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy by Subtype Chemotherapy by Subtype June 07, 2013 | Breast Cancer [1], Triple-Negative Breast Cancer [2], ASCO 2013 Breast Cancer [3], ASCO 2013 [4] By Anna Azvolinsky, PhD [5] including Jennifer A. Pietenpol, ... Access Full Source
No comments:
Post a Comment